Stockscreener 앱 받기
133.06
0.35%
0.46
시간 외 거래:
133.06
Abbott Laboratories 주식(ABT)의 최신 뉴스
Abbott’s rapid blood-based concussion test is off to the races - Fierce Biotech
The Zacks Analyst Blog Highlights GE Healthcare, Johnson & Johnson, Abbott and Boston Scientific - Yahoo
Judge throws out case against Abbott over preterm baby formulas - Chicago Tribune
One of Abbott's first federal baby formula lawsuits dismissed - Crain's Chicago Business
Abbott Beats Bellwether Formula MDL Trial in Federal Court Ruling - USA Herald
Judge throws out case against Abbott Laboratories over its preterm baby formula, days before trial was set to begin in Chicago - Yahoo
Positive Legal and Market Factors Justify Buy Rating for Abbott Laboratories - TipRanks
Judge Allows Testimony That Abbott, Mead Johnson Baby Formula Caused Disease - Insurance Journal
Winnetka crash: Raziyeh Sigary, Sediqeh Samadi identified as pedestrians killed at Church Road, Meadow Road; infant injured - ABC7 Chicago
Abbott (ABT) Launches Rapid Concussion Test with MotoAmerica - GuruFocus
Abbott Nutrition Reaches Deal With FDA To Reopen Baby Formula Plant Amid Shortage - Class Action Lawsuits
2 Stocks, 2 Decades, $200. Is This the Long-Term Dividend Play for Your Portfolio? - The Motley Fool
Abbott Laboratories Director Makes Significant Stock Sale! - TipRanks
Abbott Beats Bellwether In Formula MDL Ahead Of Trial - Law360
US judge allows testimony that Abbott and Mead Johnson preterm baby formula caused deadly disease - Reuters
Abbott Laboratories (ABT) Sees Stock Rise Following Favorable Court Ruling - GuruFocus
Abbott gains after upcoming baby formula case thrown out (ABT:NYSE) - Seeking Alpha
Abbott Laboratories First Quarter 2025 Earnings: EPS Misses Expectations - simplywall.st
Stroke Management Market Is Booming Worldwide | Abbott - openPR.com
Investors in Abbott Laboratories (NYSE:ABT) have seen notable returns of 52% over the past five years - Yahoo Finance
Abbott Laboratories Announces Executive Vice President’s Retirement - TipRanks
MotoAmerica Becomes First Sports Organization to Use Abbott's Rapid Blood Test for Concussion Evaluation On-site at Races - Yahoo Finance
Abbott Laboratories (ABT): Among the Best Stocks to Buy During Recession - Yahoo Finance
Abbott Laboratories price tries to shake off negative pressureForecast today01-05-2025 - Economies.com
MotoAmerica: More On Abbott Blood Test for Rapid Concussion Evaluation On-Site - Roadracing World
Abbott Laboratories (ABT): Jim Cramer Calls It a ‘Tour de Force’ — Why He’s Still Amazed at This Stock - Yahoo Finance
Abbott Laboratories (ABT) Announces Results of Annual Shareholders Meeting - GuruFocus
Abbott (ABT) Integrates Libre CGM Data with Epic's Health Records - GuruFocus
Abbott signs deal with Epic for CGM data integration (ABT:NYSE) - Seeking Alpha
Abbott Integrates Libre CGM’s Data with Epic’s EHR System - Medical Product Outsourcing
Abbott (ABT) Teams Up with Epic for Advanced Health Data Integra - GuruFocus
Abbott integrates Libre CGM data into Epic EHR workflows - Drug Delivery Business
Abbott Partners With Epic to Transform Diabetes Care for 280M Patients | ABT Stock News - Stock Titan
Sevoflurane Market Overall Study Report 2025-2032 | Abbott Laboratories, Baxter, Piramal Pharma Solutions - openPR.com
A Look Into Abbott Laboratories Inc's Price Over Earnings - Benzinga
Abbott Laboratories (NYSE:ABT) Unveils Breakthrough Leadless Pacemaker Advances In New Clinical Trials - simplywall.st
3 Dividend Stocks to Buy and Hold for the Next Decade - Yahoo Finance
Abbott (ABT) Unveils Promising Results from Leadless Pacemaker S - GuruFocus
The Zacks Analyst Blog Highlights Abbott Laboratories, Boston Scientific and Medtronic - Yahoo Finance
Drug Eluting Stents Market Overall Study Report 2025-2032 | - openPR.com
Abbott Laboratories (NYSE:ABT) Is Doing The Right Things To Multiply Its Share Price - Yahoo Finance
Abbott Laboratories Insiders Sold US$3.3m Of Shares Suggesting Hesitancy - simplywall.st
The health care sector is a mixed picture, but Abbott Labs is a buy. - Forbes
Abbott Stuns with Study Results in PFA Market: Is It Enough? - Medical Device and Diagnostic industry
Pesticides Market to Experience Rapid Growth Driven by Abbott - openPR.com
Abbott Laboratories Says Investigational Pacemaker Shows Safety, Performance - marketscreener.com
India Medical Nutrition Market Overall Study Report 2025-2032 | - openPR.com
Abbott has positive study results for Aveir CSP leadless pacemaker - MassDevice
Abbott Laboratories: Strategic Advancements and Market Positioning with Volt PFA Platform Drive Buy Rating - TipRanks
Abbott announces new data from its Volt CE Mark Study - TipRanks
Breakthrough Heart Technology: Abbott's Leadless Pacemaker Trial Success Launches Major Global Study - Stock Titan
New data supports Abbott Volt pulsed field ablation system - MassDevice
Abbott Laboratories Says New Clinical Study Data Showcase Long-Term, Sustained Benefits Of Abbott's Volt(TM) Pfa System For Patients With Afib - marketscreener.com
Abbott's Revolutionary AFib Treatment Achieves 83.5% Freedom from Arrhythmia in Landmark Study - Stock Titan
FDA says recall of Abbott HeartMate power unit is serious - MassDevice
FDA announces new recall of Abbott heart pump accessories over significant safety risks - Cardiovascular Business
Clinical Diagnostics Market: Trends, Growth, and Key Players - openPR.com
Medtronic seeks FDA nod for insulin pump (MDT:NYSE) - Seeking Alpha
EPD Growth in Emerging Market Supports Abbott Stock Amid Macro Woes - Yahoo Finance
0.12%
1.57%
자본화:
|
볼륨(24시간):